Genovis AB (publ.) (STO:GENO)
Sweden
· Delayed Price · Currency is SEK 24.00
-0.70 (-2.83%)
May 13, 2025, 5:20 PM CET
Genovis AB (publ.) Revenue
In the year 2024, Genovis AB (publ.) had annual revenue of 131.32M SEK, down -17.44%. Genovis AB (publ.) had revenue of 28.90M in the quarter ending December 31, 2024, with 2.69% growth.
Revenue
131.32M
Revenue Growth
-17.44%
P/S Ratio
11.96
Revenue / Employee
4.10M
Employees
32
Market Cap
1.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.32M | -27.75M | -17.44% |
| Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
| Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
| Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
| Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |
Genovis AB (publ.) News
- 6 months ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus